Resilient Apparel Brands
This carefully selected group of apparel stocks features companies with powerful brand loyalty and strong direct-to-consumer sales channels. Handpicked by professional analysts, these brands are positioned to thrive even when facing economic headwinds like tariffs.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Nike, Inc.
NKE
Current price
$76.88
As a global icon in athletic apparel with a massive and growing direct-to-consumer business, Nike is well-positioned to replicate Levi's success in us...
As a global icon in athletic apparel with a massive and growing direct-to-consumer business, Nike is well-positioned to replicate Levi's success in using brand strength to navigate economic challenges.
Lululemon Athletica Inc.
LULU
Current price
$197.66
Lululemon's powerful brand loyalty and primarily direct-to-consumer model make it a prime example of a company that can maintain premium pricing and d...
Lululemon's powerful brand loyalty and primarily direct-to-consumer model make it a prime example of a company that can maintain premium pricing and demand despite broader market pressures.
Deckers Outdoor Corp.
DECK
Current price
$105.52
Owner of the iconic UGG and HOKA brands, Deckers has a strong and profitable DTC segment that allows it to control pricing and customer relationships,...
Owner of the iconic UGG and HOKA brands, Deckers has a strong and profitable DTC segment that allows it to control pricing and customer relationships, similar to Levi's.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Strong brand identity and direct-to-consumer channels help apparel companies weather economic storms. Just as Levi Strauss raised forecasts despite tariff pressures, these companies can maintain pricing power and customer loyalty when market conditions get tough.
What You Need to Know
These companies control their own destiny through e-commerce sites and branded stores, reducing dependence on traditional retailers. This strategy provides better margin control, inventory management, and pricing power, creating a defensive advantage during economic downturns.
Why These Stocks
Each company was selected for its iconic brand recognition and significant direct-to-consumer presence. Our analysts identified businesses that mirror Levi's successful strategy, with the potential to protect margins and grow sales even when faced with external economic pressures.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+41.16%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 41.16% over the next year.
Stocks Rated Buy by Analysts
11 of 15 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Recession-Resistant Potential
These iconic brands have shown they can maintain customer loyalty even during economic downturns. Their direct-to-consumer focus gives them extra protection against market volatility.
Control Their Own Destiny
Unlike traditional retailers, these companies can adjust pricing, manage inventory, and connect directly with customers. This flexibility could help them navigate supply chain issues and tariff pressures.
The Levi's Effect
Levi Strauss showed that strong brands can thrive despite tariffs and economic headwinds. These companies share similar characteristics, positioning them to potentially replicate this impressive performance.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.